Schisandrin B can attenuate Aβ‐induced cellular damage and cognitive impairment in AD mice and may act as a potential selective ATP‐competitive GSK‐3β inhibitor, further affecting its anti‐AD effect.149. This evidence concerns the gene GSK3B and Alzheimer disease.